487 related articles for article (PubMed ID: 33053610)
1. Circulating exosomal microRNAs as emerging non-invasive clinical biomarkers in heart failure: Mega bio-roles of a nano bio-particle.
Zhou R; Wang L; Zhao G; Chen D; Song X; Momtazi-Borojeni AA; Yuan H
IUBMB Life; 2020 Dec; 72(12):2546-2562. PubMed ID: 33053610
[TBL] [Abstract][Full Text] [Related]
2. Serum Exosomal MiR-92b-5p as a Potential Biomarker for Acute Heart Failure Caused by Dilated Cardiomyopathy.
Wu T; Chen Y; Du Y; Tao J; Zhou Z; Yang Z
Cell Physiol Biochem; 2018; 46(5):1939-1950. PubMed ID: 29719295
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic, prognostic, and therapeutic potential of exosomal microRNAs in renal cancer.
Yu X; Du Z; Zhu P; Liao B
Pharmacol Rep; 2024 Apr; 76(2):273-286. PubMed ID: 38388810
[TBL] [Abstract][Full Text] [Related]
4. Inflammation-associated microRNA changes in circulating exosomes of heart failure patients.
Beg F; Wang R; Saeed Z; Devaraj S; Masoor K; Nakshatri H
BMC Res Notes; 2017 Dec; 10(1):751. PubMed ID: 29258606
[TBL] [Abstract][Full Text] [Related]
5. Stem cell-derived and circulating exosomal microRNAs as new potential tools for diabetic nephropathy management.
Peng L; Chen Y; Shi S; Wen H
Stem Cell Res Ther; 2022 Jan; 13(1):25. PubMed ID: 35073973
[TBL] [Abstract][Full Text] [Related]
6. Coronary Artery-Bypass-Graft Surgery Increases the Plasma Concentration of Exosomes Carrying a Cargo of Cardiac MicroRNAs: An Example of Exosome Trafficking Out of the Human Heart with Potential for Cardiac Biomarker Discovery.
Emanueli C; Shearn AI; Laftah A; Fiorentino F; Reeves BC; Beltrami C; Mumford A; Clayton A; Gurney M; Shantikumar S; Angelini GD
PLoS One; 2016; 11(4):e0154274. PubMed ID: 27128471
[TBL] [Abstract][Full Text] [Related]
7. Exosomal microRNAs miR-30d-5p and miR-126a-5p Are Associated with Heart Failure with Preserved Ejection Fraction in STZ-Induced Type 1 Diabetic Rats.
Huang JP; Chang CC; Kuo CY; Huang KJ; Sokal EM; Chen KH; Hung LM
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886860
[TBL] [Abstract][Full Text] [Related]
8. Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor.
Warnecke-Eberz U; Chon SH; Hölscher AH; Drebber U; Bollschweiler E
Tumour Biol; 2015 Jun; 36(6):4643-53. PubMed ID: 25631748
[TBL] [Abstract][Full Text] [Related]
9. Exosomal microRNA-4661-5p-based serum panel as a potential diagnostic biomarker for early-stage hepatocellular carcinoma.
Cho HJ; Baek GO; Seo CW; Ahn HR; Sung S; Son JA; Kim SS; Cho SW; Jang JW; Nam SW; Cheong JY; Eun JW
Cancer Med; 2020 Aug; 9(15):5459-5472. PubMed ID: 32537885
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Genetic Analysis of KATP Variants With Heart Failure Risk in Patients With Decreased Serum ApoA-I Levels.
Liu C; Lai Y; Pei J; Huang H; Zhan J; Ying S; Shen Y
J Clin Endocrinol Metab; 2021 Jul; 106(8):2264-2278. PubMed ID: 33982099
[TBL] [Abstract][Full Text] [Related]
11. miRNA profiling of urinary exosomes to assess the progression of acute kidney injury.
Sonoda H; Lee BR; Park KH; Nihalani D; Yoon JH; Ikeda M; Kwon SH
Sci Rep; 2019 Mar; 9(1):4692. PubMed ID: 30886169
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNA-150-5p as a novel biomarker for advanced heart failure: A genome-wide prospective study.
Scrutinio D; Conserva F; Passantino A; Iacoviello M; Lagioia R; Gesualdo L
J Heart Lung Transplant; 2017 Jun; 36(6):616-624. PubMed ID: 28259597
[TBL] [Abstract][Full Text] [Related]
13. Circulating exosomal miR-92b-5p is a promising diagnostic biomarker of heart failure with reduced ejection fraction patients hospitalized for acute heart failure.
Wu T; Chen Y; Du Y; Tao J; Li W; Zhou Z; Yang Z
J Thorac Dis; 2018 Nov; 10(11):6211-6220. PubMed ID: 30622793
[TBL] [Abstract][Full Text] [Related]
14. Serum Exosomal MicroRNA, miR-10b-5p, as a Potential Diagnostic Biomarker for Early-Stage Hepatocellular Carcinoma.
Cho HJ; Eun JW; Baek GO; Seo CW; Ahn HR; Kim SS; Cho SW; Cheong JY
J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31968558
[TBL] [Abstract][Full Text] [Related]
15. Circulating Exosomal miRNAs as Novel Biomarkers for Stable Coronary Artery Disease.
Zhang P; Liang T; Chen Y; Wang X; Wu T; Xie Z; Luo J; Yu Y; Yu H
Biomed Res Int; 2020; 2020():3593962. PubMed ID: 33381550
[TBL] [Abstract][Full Text] [Related]
16. Plasma exosome-derived microRNAs expression profiling and bioinformatics analysis under cross-talk between increased low-density lipoprotein cholesterol level and ATP-sensitive potassium channels variant rs1799858.
Liu C; Lai Y; Ying S; Zhan J; Shen Y
J Transl Med; 2020 Dec; 18(1):459. PubMed ID: 33272292
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid antibody-induced miR-146a-3p drives trophoblast interleukin-8 secretion through activation of Toll-like receptor 8.
Gysler SM; Mulla MJ; Guerra M; Brosens JJ; Salmon JE; Chamley LW; Abrahams VM
Mol Hum Reprod; 2016 Jul; 22(7):465-74. PubMed ID: 27029214
[TBL] [Abstract][Full Text] [Related]
18. Exo-miR-144-3p as a promising diagnostic biomarker for depressive symptoms in heart failure.
Wang R; Huang K; Feng Y; Duan J; Ying H; Shi Q; Zhang Y; Jiang R; Yang L
Neurobiol Dis; 2024 Mar; 192():106415. PubMed ID: 38266934
[TBL] [Abstract][Full Text] [Related]
19. Exosome-Derived Mediators as Potential Biomarkers for Cardiovascular Diseases: A Network Approach.
Moreira-Costa L; Barros AS; Lourenço AP; Leite-Moreira AF; Nogueira-Ferreira R; Thongboonkerd V; Vitorino R
Proteomes; 2021 Feb; 9(1):. PubMed ID: 33535467
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective microRNAs: Lessons from stem cell-derived exosomal microRNAs to treat cardiovascular disease.
Moghaddam AS; Afshari JT; Esmaeili SA; Saburi E; Joneidi Z; Momtazi-Borojeni AA
Atherosclerosis; 2019 Jun; 285():1-9. PubMed ID: 30939341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
